Joseph M Colacino

Years Active: 2018-2021
Publications (10 Years): 2

PTC Therapeutics, Inc.

Weill Cornell Graduate School of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

PTC Therapeutics, Inc. Mar 10 2003

United States

Senior Vice President :: Drug Discovery

Education History

Weill Cornell Graduate School of Medical Sciences Sep 01 1980 - May 01 1985

United States

PHD :: Sloan Kettering Division

Publications

Finith Jernigan, Arthur Branstrom, John D Baird, Liangxian Cao, Mandar Dali, Bansri Furia, Min Jung Kim, Kylie O'Keefe, Ronald Kong, Oscar L Laskin, Joseph M Colacino, Mark Pykett, Anna Mollin, Josephine Sheedy, Melissa Dumble, Young-Choon Moon, Richard Sheridan, Tobias Mühlethaler, Robert J Spiegel, Andrea E Prota, Michel O Steinmetz, Marla Weetall
Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent. Molecular cancer therapeutics 20 (10) (2021)
Liangxian Cao, Marla Weetall, Christopher Trotta, Katherine Cintron, Jiyuan Ma, Min Jung Kim, Bansri Furia, Charles Romfo, Jason D Graci, Wencheng Li, Joshua Du, Josephine Sheedy, Jean Hedrick, Nicole Risher, Shirley Yeh, Hongyan Qi, Tamil Arasu, Seongwoo Hwang, William Lennox, Ronald Kong, Janet Petruska, Young-Choon Moon, John Babiak, Thomas W Davis, Allan Jacobson, Neil G Almstead, Art Branstrom, Joseph M Colacino, Stuart W Peltz
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties. Molecular cancer therapeutics 18 (1) (2018)

Joseph M Colacino.css-eqlu8i{font-size:small;padding-left:4px;}